Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -12.30M
March 31, 2026 -12.88M
December 31, 2025 96.06M
September 30, 2025 100.47M
June 30, 2025 101.09M
March 31, 2025 101.60M
December 31, 2024 -6.713M
September 30, 2024 -10.85M
June 30, 2024 -9.985M
March 31, 2024 -9.604M
December 31, 2023 -7.683M
September 30, 2023 -7.261M
June 30, 2023 -6.172M
Date Value
March 31, 2023 -4.134M
December 31, 2022 -3.786M
September 30, 2022 -2.809M
June 30, 2022 -3.303M
March 31, 2022 -3.966M
December 31, 2021 -4.812M
September 30, 2021 -3.789M
June 30, 2021 -3.155M
March 31, 2021 -2.502M
December 31, 2020 -1.813M
September 30, 2020 -0.951M
June 30, 2020 -0.541M
March 31, 2020 -0.259M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 0.00
Manhattan Scientifics, Inc. --
Exicure, Inc. -0.37M
Absci Corp. -9.533M
Celularity, Inc. -3.174M